Nisa Investment Advisors, LLC Adverum Biotechnologies, Inc. Transaction History

Nisa Investment Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$0.81 - $1.34 $834 - $1,380	-1,030 Closed	0 $0
Q3 2021 Oct 18, 2021	SELL	$2.08 - $3.6 $23,400 - $40,500	-11,250 Reduced 91.61%	1,030 $2,000
Q2 2021 Aug 06, 2021	BUY	$3.36 - $10.56 $25,368 - $79,728	7,550 Added 159.62%	12,280 $43,000
Q4 2020 Jan 25, 2021	BUY	$9.84 - $14.26 $13,284 - $19,251	1,350 Added 39.94%	4,730 $51,000
Q3 2020 Oct 20, 2020	BUY	$10.3 - $21.64 $27,810 - $58,428	2,700 Added 397.06%	3,380 $35,000
Q1 2020 Apr 17, 2020	SELL	$7.98 - $16.32 $1,755 - $3,590	-220 Reduced 24.44%	680 $7,000
Q3 2019 Oct 17, 2019	BUY	$5.24 - $15.89 $4,716 - $14,301	900 New	900 $5,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.